Seoul, South Korea

Seongkyu Kim

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Yuhan Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seongkyu Kim. Retrieved from https://idiyas.com/inventor/seongkyu-kim-sz6figgl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seongkyu Kim: Innovator in Pharmaceutical Composition

Introduction

Seongkyu Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for oral administration.

Latest Patents

One of his notable patents is a pharmaceutical composition for oral administration comprising an aminopyrimidine derivative or its salt. The patent details a composition that includes N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pirimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, also known as Lazertinib, as an active ingredient. This composition is designed to enhance the efficacy of oral medications.

Career Highlights

Seongkyu Kim is associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has been instrumental in advancing pharmaceutical research and development.

Collaborations

He has collaborated with notable colleagues, including Deokkyu Lee and Soo-Won Kim, to further enhance the impact of their research in the pharmaceutical industry.

Conclusion

Seongkyu Kim's innovative work in pharmaceutical compositions exemplifies the importance of research and collaboration in advancing medical science. His contributions continue to influence the field and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…